Cancer Immunology, Immunotherapy

Published by Springer

Open access · CC BY-NC-ND · In DOAJ · Germany · Immunotherapy and Immune Responses

Journal at a glance

ISSN

14320851

Publisher

Springer

Country

Germany

Language

en

License

CC BY-NC-ND

Also known as: Cancer Immunol Immunother (Abbreviation), Cancer immunology and immunotherapy (Alternate title), CII (Alternate title), Cancer immunology, immunotherapy (Print) (Alternate title), CII. Cancer immunology and immunotherapy (Alternate title)

Indexing

• DOAJ: Active
• Medline: Active
• Pubmed: Active

Metrics

Subjects

• Immunotherapy and Immune Responses
• Cancer Immunotherapy and Biomarkers
• Immune Cell Function and Interaction
• CAR-T cell therapy research
• T-cell and B-cell Immunology
• Monoclonal and Polyclonal Antibodies Research
• Immune cells in cancer
• Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• Deep learning integration of single-cell and spatial transcriptomics reveals a neutrophil-associated mesenchymal niche and a candidate translocon dependency in lung adenocarcinoma (2026)
• Characterization of the immune status in the tumor microenvironment of solid cancers with chromosomal instability (2026)
• Efficacy and safety of anti-PD-1 combined with IFN-α1b with or without anlotinib as the first-line therapy in patients with unresectable advanced melanoma: a real-world cohort study (2026)
• Integration of a severe immune-related adverse events predictive model with efficacy biomarkers enables precise stratification in NSCLC immunotherapy: insights from the phase 3 ORIENT-11 study (2026)
• Efficacy and safety of sintilimab and lenvatinib combined with locoregional therapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter cohort study (2026)

Similar journals

• Frontiers in Immunology — Switzerland · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 6 shared subjects in total
• Journal for ImmunoTherapy of Cancer — United Kingdom · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 6 shared subjects in total
• JCI Insight — United States · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 6 shared subjects in total
• Journal of Immunotherapy — United States · — · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 6 shared subjects in total
• Immune Network — South Korea · Open access · Same subject: CAR-T cell therapy research, Same subject: Immune Cell Function and Interaction, 6 shared subjects in total
• ImmunoTargets and Therapy — New Zealand · Open access · Same subject: CAR-T cell therapy research, Same subject: Cancer Immunotherapy and Biomarkers, 6 shared subjects in total

Sources: DOAJ, OpenAlex, NLM Catalog, Crossref · Last verified 2026-09-05

Journal homepage · Author guidelines